| Literature DB >> 32087753 |
Carolin Moessnang1, Sarah Baumeister2, Julian Tillmann3,4, David Goyard5, Tony Charman3, Sara Ambrosino6, Simon Baron-Cohen7, Christian Beckmann8,9, Sven Bölte10,11, Carsten Bours8,9, Daisy Crawley12, Flavio Dell'Acqua12,13, Sarah Durston6, Christine Ecker14, Vincent Frouin5, Hannah Hayward12, Rosemary Holt7, Mark Johnson15, Emily Jones15, Meng-Chuan Lai7,16,17, Michael V Lombardo7,18, Luke Mason15, Marianne Oldenhinkel8,9, Antonio Persico19,20, Antonia San José Cáceres12, Will Spooren21, Eva Loth12,13, Declan G M Murphy12,13, Jan K Buitelaar8,9,22, Tobias Banaschewski2, Daniel Brandeis2,23,24, Heike Tost25, Andreas Meyer-Lindenberg25.
Abstract
BACKGROUND: Autism spectrum disorder (ASD) is a neurodevelopmental condition with key deficits in social functioning. It is widely assumed that the biological underpinnings of social impairment are neurofunctional alterations in the "social brain," a neural circuitry involved in inferring the mental state of a social partner. However, previous evidence comes from small-scale studies and findings have been mixed. We therefore carried out the to-date largest study on neural correlates of mentalizing in ASD.Entities:
Keywords: Animated shapes; Autism; Autism spectrum disorder; Development; Mentalizing; Multi-site; Social brain; Theory of mind; fMRI
Mesh:
Year: 2020 PMID: 32087753 PMCID: PMC7036196 DOI: 10.1186/s13229-020-0317-x
Source DB: PubMed Journal: Mol Autism Impact factor: 7.509
Sample description
| ASD | TD | Statistics: ASD vs. TD | |
|---|---|---|---|
| Total | 205 | 189 | |
| Demographics | |||
| Sex (male/female) | 151/54 | 123/66 | |
| Age (years) | 17.9 ± 5.4 (7.1–30.6) | 18.0 ± 5.5 (7.6–31.0) | |
| IQ (full IQ) | 107.1 ± 14.2 (75.6–148.0) | 108.5 ± 12.1 (76.8–142.0) | |
| Handedness (right/left/ambidext/unknown) | 146/22/8/29 | 131/16/4/38 | |
| Medication use (% of subjects)1 | 40.5 | 5.8 | |
| In-scanner performance | |||
| Mean framewise displacement (FD; in mm)2 | .14 ± .08 (.03–.47) | .12 ± .08 (.03–.42) | |
| Volumes with FD > 0.5 mm (%) | 3.55 ± 4.74 (0–19.40) | 3.17 ± 4.33 (0–19.73) | |
| Signal-to-noise ratio | 9.7 ± 1.3 (6.5–13.8) | 9.9 ± 1.4 (6.5–13.8) | |
| Task accuracy | .81 ±.13 (.33–1.0) | .83 ± .13 (0–1.0) | |
| Clinical characteristics | |||
| ADI-R3 | |||
| Social interaction | 15.5 ± 6.7 (0–29) | ||
| Communication | 12.6 ± 5.6 (0–26) | ||
| RRB | 4.5 ± 2.6 (0–12) | ||
| ADOS-24 | |||
| Social affect | 5.7 ± 2.5 (1–10) | ||
| RRB | 4.7 ± 2.6 (1–10) | ||
| Total | 5.0 ± 2.6 (1–10) | ||
| SRS-2 (parent report)5 | |||
| Raw score | 86.1 ± 30.6 (21–163) | 19.9 ± 14.4 (1–74) | |
| 69.2 ± 12.1 (43–90) | 45.1 ± 5.8 (37–66) | ||
| DAWBA comorbidities6 | |||
| ADHD symptoms | 1.6 ± 1.6 (0–5) | .2 ± .7 (0–3) | |
| Depression symptoms | 1.1 ± 1.3 (0–5) | .4 ± .7 (0–4) | |
| Anxiety symptoms | 2.5 ± 1.3 (0–5) | 1.2 ± .9 (0–4) | |
Participant characteristics, split by sample and age group. If not otherwise indicated, numbers reflect mean ± standard deviation, followed by value range (minimum–maximum)
1Percentage of participants taking medication prescribed for behavioral or neurological problems. Medication data was available for 132 ASD and 78 TD participants. See Additional file 1: Table S1 more information on medication
2Motion was assessed as mean framewise displacement according to [38]
3Autism Diagnostic Interview-Revised (ADI-R [36]) scores were computed for reciprocal interaction (social interaction), communication, and restrictive, repetitive stereotyped behaviors and interests (RRB). ADI-R scores reflect historical symptom severity (age 4–5 years) and were available for 197 ASD participants
4Autism Diagnostic Observation Schedule 2 (ADOS-2 [35]). Calibrated severity scores [39] were computed for social affect, RRB, and the overall total score. ADOS-2 scores reflect current symptom severity and were available for 198 ASD participants
5Total raw and total T score (sex and age normalized) on the Social Responsiveness Scale-2 (SRS-2 [40]). SRS-2 scores were available for 247 participants (i.e., TD adults are excluded from this measure; see Additional file 1 for analyses using self-reported SRS-2 scores). The raw SRS-2 scores were used in our analyses
6Comorbid symptoms of ADHD, depression, and anxiety were assessed with the Development and Well-Being Assessment (DAWBA [41]), generating six levels (ordinal scores 0 to 5) of prediction of the probability of a disorder (~ 0.1%, ~ 0.5%, ~ 3%, ~ 15%, ~ 50%, > 70%). DAWBA scores were available for 167 ASD and 146 TD participants for depression, 140 ASD and 73 TD participants for ADHD, and 183 ASD and 167 TD participants for anxiety
Video categorization accuracy for the full sample, youth sample (< 18 years of age), and adult sample (≥ 18 years of age)
| Accuracy (in %) | ASD | TD | ME diagnosis | ME age | IA age × diagnosis |
|---|---|---|---|---|---|
| Overall | 81.4 ± 13.4 | 83.2 ± 13.4 | |||
| ToM video | 82.7 ± 20.5 | 86.2 ± 19.0 |
Significant effects printed in bold; ASD autism spectrum disorder, TD typical development, ME main effect, IA interaction effect
Fig. 1Overall categorization accuracy. Linear least square regression fits (third level polynomial) for TD (gray) and ASD (black) are shown for the full sample. Shaded areas represent 95% confidence intervals. Non-parametric correlation coefficients (Spearman’s rho) are reported for all subjects and separately for TD and ASD subjects.*p < .05, **p < .01
Fig. 2Functional activation to spontaneous mentalizing elicited by increasing social significance of animated video clips. a Render brains illustrate the positive effect of task (i.e., effect of increasing social significance) in the full sample. Scatter plots highlight functional responses in selected peak voxels in the right pSTS (left) and dmPFC (right). b Render brains illustrate the positive effect of age in the full sample (left) and youth sample (right), complemented by scatter plots of peak voxels in the right anterior temporal pole (left) and right anterior insula (right). Associations with age are displayed using a linear model fit (95% confidence interval indicated as shaded area). Distributions of peak voxel activation in cases and controls were compared using the Kolmogorov-Smirnov test, which suggested no evidence for unequal distributions (statistics for peak at [57, − 46, 11], full sample: D(205,189)* = .065, p = .789; for peak at [− 6, 53, 32], full sample: D(205,189)* = .044, p = .990, for peak at [51, 2, − 19], full sample: D(205,189)* = .061, p = .853; for peak at [30, 20, − 4], youth sample: D(111,105)* = .081, p = .855; adult sample: D(93,84)* = .140, p = .327). Distribution mean and 25th/75th percentiles are indicated as thick and thin lines within bee swarm plots, respectively. For illustration purposes, render brains are displayed at a significance threshold of t = 3 using BrainNet Viewer (http://www.nitrc.org/projects/bnv/). TD, typically developing; ASD, autism spectrum disorder; D*, test statistic of the Kolmogorov-Smirnov test
Whole-brain parametric effects of increasing mentalizing demands on brain activation
| Effect/contrast | Sample | Region | ||||||
|---|---|---|---|---|---|---|---|---|
| Within-subject effects | ||||||||
| Effect of task | ||||||||
| Mentalizing demands: parametric increase | Full | 3036 | Superior temporal gyrus | 57 | − 46 | 11 | 28.69 | < .001 |
| Middle occipital gyrus [area hOc4lp] | 27 | − 91 | 2 | 24.99 | < .001 | |||
| Superior temporal gyrus | 48 | − 22 | − 7 | 22.04 | < .001 | |||
| Inferior temporal gyrus [area FG4] | 42 | − 52 | − 13 | 21.25 | < .001 | |||
| Temporal pole | 54 | 14 | − 19 | 16.71 | < .001 | |||
| 4251 | Middle temporal gyrus | − 54 | − 52 | 14 | 26.84 | < .001 | ||
| Middle occipital gyrus [area hOc4lp] | − 27 | − 91 | − 4 | 23.03 | < .001 | |||
| Fusiform gyrus [area FG4] | − 39 | − 55 | − 10 | 21.55 | < .001 | |||
| Cerebellum [lobule VIIa crusI (hem)] | − 24 | − 76 | − 34 | 16.49 | < .001 | |||
| Inferior frontal gyrus, pars triangularis | − 51 | 20 | 20 | 16.40 | < .001 | |||
| 1115 | Precuneus | 6 | − 52 | 38 | 18.85 | < .001 | ||
| 868 | Inferior frontal gyrus, pars triangularis [area 45] | 51 | 26 | 17 | 14.96 | < .001 | ||
| Precentral gyrus | 45 | 5 | 50 | 12.57 | < .001 | |||
| 925 | Dorsomedial prefrontal gyrus | − 6 | 53 | 32 | 13.98 | < .001 | ||
| Supplementary motor area | 9 | 17 | 65 | 10.82 | < .001 | |||
| 56 | Cerebellum [lobule IX (hem)] | − 6 | − 52 | − 40 | 11.02 | < .001 | ||
| 553 | Thalamus [thalamus: prefrontal] | 9 | − 13 | 8 | 9.46 | < .001 | ||
| 27 | Cerebellum vermis [lobule I IV (hem)] | 0 | − 46 | − 16 | 6.06 | < .001 | ||
| 6 | Middle cingulate cortex | 0 | − 16 | 41 | 5.44 | .001 | ||
| 2 | Middle frontal gyrus | − 24 | 23 | 44 | 4.60 | .025 | ||
| Between-subject effects | ||||||||
| Effect of age | ||||||||
| Age: linear decrease | Full | 12 | Medial temporal pole | 51 | 2 | − 19 | 5.04 | .004 |
| Age: linear decrease | Youth | 249 | Superior parietal lobule [area 7P (SPL)] | − 27 | − 58 | 56 | 6.37 | .000 |
| 207 | Superior parietal lobule [area 7P (SPL)] | 18 | − 67 | 53 | 5.75 | .000 | ||
| Precuneus | − 6 | − 76 | 44 | 5.45 | .001 | |||
| Superior parietal lobule [area 7A (SPL)] | 18 | − 58 | 62 | 5.30 | .002 | |||
| 35 | Inferior parietal lobule [area hIP1 (IPS)] | − 36 | − 40 | 38 | 5.14 | .004 | ||
| Inferior parietal lobule [area PFt (IPL)] | − 48 | − 34 | 41 | 4.78 | .017 | |||
| 35 | Inferior parietal lobule [area 2] | 48 | − 34 | 47 | 5.01 | .007 | ||
| 13 | Middle cingulate gyrus | 6 | 26 | 38 | 4.85 | .013 | ||
| Anterior cingulate gyrus | 6 | 32 | 26 | 4.60 | .034 | |||
| 20 | Superior frontal gyrus | 24 | − 1 | 47 | 4.83 | .014 | ||
| 11 | Anterior insula | 30 | 20 | − 4 | 4.77 | .017 | ||
| 5 | Supramarginal gyrus (area PFt (IPL)] | 63 | − 22 | 35 | 4.72 | .021 | ||
| 8 | Inferior parietal lobule [area 7PC (SPL)] | 33 | − 46 | 53 | 4.72 | .021 | ||
| 2 | Middle frontal gyrus | 45 | 38 | 20 | 4.60 | .034 | ||
| 1 | Postcentral gyrus [area 4p] | 33 | − 31 | 50 | 4.57 | .037 | ||
| Effect of diagnosis (categorical) | ||||||||
| No sign. effect | ||||||||
| Effect of parent-reported autism traits (dimensional) | ||||||||
| Linear increase | Full (no TD adult1) | 4 | Inferior parietal lobule [area PFm (IPL)] | 54 | − 55 | 38 | 4.82 | .021 |
| 10SVC | dmPFC (combined mask) | 3 | 62 | 23 | 3.88 | .011SVC | ||
| 15SVC | dmPFC (combined mask) | − 9 | 53 | 38 | 3.49 | .035SVC | ||
| Linear increase | Youth | 23SVC | dmPFC (combined mask) | 3 | 56 | 26 | 3.77 | .016SVC |
| 8SVC | dmPFC (combined mask) | − 15 | 50 | 35 | 3.43 | .046SVC | ||
Regions were classified according to the Automated Anatomical Labeling Atlas [47]. If applicable, functional labels were added in square brackets based on Anatomical Probability Maps (Anatomy toolbox [48]). x-, y-, and z-coordinates (MNI) and statistical information refer to peak voxels in the identified clusters. p values are adjusted for family-wise error correction for multiple comparisons across the whole brain, or across the combined mask of the right pSTS and dmPFC using small volume correction (SVC). Age and sex were included as covariates in the analysis. SPL superior parietal lobule, IPS intraparietal sulcus, IPL inferior parietal lobule, TD typically developing, pSTS posterior superior temporal sulcus, dmPFC dorsomedial prefrontal cortex
1 no parent-reported SRS-scores available for TD adults
Fig. 3a Brain sections (left) illustrate the association of a continuous measure of autism traits, as assessed as parent-reported scores of the Social Responsiveness Scale-2 (SRS-2), with functional responses to increasing mentalizing demands in the dmPFC in individuals with ASD. The outline of the ROI in the dmPFC is displayed in blue. A scatter plot (right) demonstrates the distribution of autism trait scores and peak voxel activation in cases and controls, including linear model fits for each group. The 95% confidence interval for the significant linear model fit in the ASD group is displayed in gray. b Brain sections (left) illustrate the case-control difference for the specific contrast ToM > goal-directed in the dmPFC ROI (outlined in blue) in the youth sample. Scatter plots (right) display the distributions of peak voxel contrast estimates in the youth and adult sample, with mean and inner quartiles (25th to 75th percentile) indicated as thick and thin lines, respectively
| Site | Ethics committee | ID/reference no. |
|---|---|---|
| KCL, UCAM | London Queen Square Health Research, Authority Research Ethics Committee | 13/LO/1156 |
| RUNMC, UMCU | Instituut Waarborging Kwaliteit en Veiligheid, Commissie Mensgebonden Onderzoek, Regio Arnhem-Nijmegen (Radboud University Medical Centre Institute Ensuring, Quality and Safety Committee on Research Involving Human Subjects Arnhem-Nijmegen) | 2013/455 |
| CIMH | UMM Universitatsmedizin Mannheim, Medizinische Ethik Commission II (UMM University Medical Mannheim, Medical Ethics Commission II) | 2014-540 N-MA |
| UCBM | Università Campus Bio-Medico di Roma, Comitato Etico (University Campus Bio-Medical Ethics Committee of Rome) | 18/14 PAR ComET CBM |